ENSC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ensysce Biosciences Inc (ENSC) is not a strong buy for a beginner, long-term investor at this time. The technical indicators show bearish trends, there are no positive trading signals from Intellectia Proprietary Trading Signals, and the company's financial performance shows declining net income and EPS despite revenue growth. Additionally, there are no recent news catalysts, analyst ratings, or significant insider or hedge fund activity to support a buy decision.
The technical indicators for ENSC are bearish. The MACD histogram is negative and expanding downward, RSI is neutral at 45.534, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point (0.532) and closer to its support levels (S1: 0.472, S2: 0.436).
Revenue increased by 44.39% YoY in Q4 2025, and gross margin remains at 100%.
Net income dropped by -22.35% YoY, and EPS fell significantly by -74.39% YoY. No recent news or significant trading trends from insiders or hedge funds. Technical indicators are bearish.
In Q4 2025, revenue increased to $1,882,336 (up 44.39% YoY), but net income dropped to -$2,767,648 (down -22.35% YoY), and EPS fell to -0.74 (down -74.39% YoY). Gross margin remained steady at 100%.
No analyst ratings or price target changes available.
